Zurich Cantonal Bank’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Sell
35,021
-20,654
-37% -$273K ﹤0.01% 1924
2026
Q1
$767K Buy
55,675
+6,353
+13% +$95.7K ﹤0.01% 1586
2025
Q4
$889K Buy
49,322
+4,653
+10% +$83.6K ﹤0.01% 1412
2025
Q3
$828K Hold
44,669
﹤0.01% 1402
2025
Q2
$715K Buy
44,669
+23,259
+109% +$415K ﹤0.01% 1435
2025
Q1
$416K Sell
21,410
-2,183
-9% -$45.9K ﹤0.01% 1705
2024
Q4
$520K Buy
23,593
+2,183
+10% +$42K ﹤0.01% 1601
2024
Q3
$361K Hold
21,410
﹤0.01% 1760
2024
Q2
$256K Sell
21,410
-5,452
-20% -$60.9K ﹤0.01% 1915
2024
Q1
$298K Hold
26,862
﹤0.01% 1816
2023
Q4
$233K Buy
26,862
+11,771
+78% +$91.5K ﹤0.01% 2001
2023
Q3
$115K Buy
15,091
+4,672
+45% +$35.1K ﹤0.01% 2288
2023
Q2
$75K Buy
10,419
+7,821
+301% +$45.6K ﹤0.01% 2470
2023
Q1
$15.8K Buy
+2,598
New +$14.1K ﹤0.01% 2778

Other funds holding CLBT

Zurich Cantonal Bank's CLBT Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its Cellebrite (CLBT) stake by 37% in Q2 2026, selling an estimated $273K and leaving 35,021 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Zurich Cantonal Bank first reported a position in CLBT in Q1 2023 and has held it in 14 quarters since. The position peaked at $889K in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Zurich Cantonal Bank held 35,021 shares of Cellebrite worth $511K as of Q2 2026.
  • Zurich Cantonal Bank sold 20,654 Cellebrite shares in Q2 2026, an estimated $273K.
  • Cellebrite made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1924 holding.
  • Zurich Cantonal Bank first reported a position in Cellebrite in Q1 2023 and has held it in 14 quarters since.
  • Zurich Cantonal Bank's Cellebrite position peaked at $889K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.